Has the Time Come to Be More Aggressive With Bariatric Surgery in Obese Patients With Chronic Systolic Heart Failure?
- 151 Downloads
Purpose of Review
Obesity is a strong risk factor for the development of heart failure (HF). Diet, exercise, and weight-loss pharmacotherapies have limited potential to achieve significant and sustainable weight loss, especially in patients with symptomatic systolic HF. This review seeks to determine the role of bariatric surgery for patients with systolic HF and obesity.
Bariatric surgeries such as the laparoscopic sleeve gastrectomy (LSG) and Roux-en-Y gastric bypass (RYGB) represent the most successful long-term strategy for achieving weight loss and diabetes and hypertension remission in the general obese population. These benefits translate to reductions in cardiovascular events and mortality, as well as improvements in myocardial structure and function. There is also now data supporting the safety of LSG or RYGB in patients with systolic dysfunction and a reduction in HF admissions post-operatively.
Current literature and clinical experience suggest that the most appropriate bariatric surgery candidates with HF are patients aged < 50–60 years, with severely depressed systolic function and NYHA II-III symptoms, who have failed non-surgical strategies and have a high likelihood of future cardiac transplantation candidacy after weight loss. This review seeks to determine the role of bariatric surgery for patients with systolic HF and obesity.
KeywordsHeart failure Cardiomyopathy Myocardium Nutrition Obesity Bariatric surgery
Compliance with Ethical Standards
Conflict of Interest
The author declares that she has no conflicts of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
- 4.Hales CM, Carroll MD, Fryar CD, Ogden CL. Prevalence of obesity among adults and youth: United States, 2015–2016. NCHS Data Brief. 2017;1–8.Google Scholar
- 5.• Joyce E, Lala A, Stevens SR, Cooper LB, Abouezzeddine OF, Groarke JD, et al. Prevalence, profile, and prognosis of severe obesity in contemporary hospitalized heart failure trial populations. JACC Heart Fail. 2016;4:923–31. This report describes the BMI distribution in contemporary Heart Failure Network inpatient clinical trials and reveals a high prevalence of obesity in HF. Subjects with BMI ≥ 40 kg/m 2 were younger, more often female, hypertensive, diabetic, and more likely to have HFpEF. CrossRefPubMedGoogle Scholar
- 11.Pocock SJ, McMurray JJV, Dobson J, Yusuf S, Granger CB, Michelson EL, et al. Weight loss and mortality risk in patients with chronic heart failure in the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) programme. Eur Heart J. 2008;29:2641–50.CrossRefPubMedGoogle Scholar
- 19.Cozzolino D, Grandone A, Cittadini A, Palmiero G, Esposito G, De Bellis A, et al. Subclinical myocardial dysfunction and cardiac autonomic dysregulation are closely associated in obese children and adolescents: the potential role of insulin resistance. PLoS One. 2015;10:e0123916.CrossRefPubMedPubMedCentralGoogle Scholar
- 31.Perego L, Pizzocri P, Corradi D, Maisano F, Paganelli M, Fiorina P, et al. Circulating leptin correlates with left ventricular mass in morbid (grade III) obesity before and after weight loss induced by bariatric surgery: a potential role for leptin in mediating human left ventricular hypertrophy. J Clin Endocrinol Metab. 2005;90:4087–93.CrossRefPubMedGoogle Scholar
- 37.Smith CCT, Dixon RA, Wynne AM, Theodorou L, Ong S-G, Subrayan S, et al. Leptin-induced cardioprotection involves JAK/STAT signaling that may be linked to the mitochondrial permeability transition pore. AJP: Heart Circ Physiol. 2010;299:H1265–70.Google Scholar
- 43.Margulies KB, Hernandez AF, Redfield MM, Givertz MM, Oliveira GH, Cole R, et al. For the NHLBI heart failure clinical research network. Effects of liraglutide on clinical stability among patients with advanced heart failure and reduced ejection fraction. JAMA. 2016;316:500–8.CrossRefPubMedPubMedCentralGoogle Scholar
- 46.NIH conference. Gastrointestinal surgery for severe obesity. Consensus Development Conference Panel 1991. p. 956–961.Google Scholar
- 48.Poirier P, Cornier MA, Mazzone T, Stiles S, Cummings S, Klein S, et al. On behalf of the American Heart Association obesity Committee of the Council on nutrition, physical activity, and metabolism. Bariatric surgery and cardiovascular risk factors: a scientific statement from the American Heart Association. Circulation. 2011;123:1683–701.CrossRefPubMedGoogle Scholar
- 50.• Adams TD, Davidson LE, Litwin SE, Kim J, Kolotkin RL, Nanjee MN, et al. Weight and metabolic outcomes 12 years after gastric bypass. N Engl J Med. 2017;377:1143–55. This 12-year observational study describes clinical outcomes for 1156 patients with severe obesity who either underwent RYGB, sought but did not undergo surgery or did not seek surgery. It shows long-term durability of surgical weight loss and sustained remission of type 2 diabetes, hypertension and hyperlipidemia, with 51% of patients with pre-operative diabetes have sustained diabetes remission at 12 years. CrossRefPubMedPubMedCentralGoogle Scholar
- 53.• Schauer PR, Bhatt DL, Kirwan JP, Wolski K, Aminian A, Brethauer SA, et al. Bariatric surgery versus intensive medical therapy for diabetes—5-year outcomes. N Engl J Med. 2017;376:641–51. The most recent STAMPEDE report describes the outcomes at 5 years after randomization to optimal medical therapy vs RYGB vs laparoscopic sleeve gastrectomy for type 2 diabetes control. The surgical groups achieved the greatest remission from diabetes as well as the more favorable weight loss and quality of life profiles. CrossRefPubMedPubMedCentralGoogle Scholar
- 57.•• Vest AR, Patel P, Schauer PR, Satava ME, Cavalcante JL, Brethauer S, et al. Clinical and echocardiographic outcomes after bariatric surgery in obese patients with left ventricular systolic dysfunction. Circ Heart Fail. 2016;9:e002260. This retrospective cohort study was the first to report the weight loss efficacy and surgical safety of bariatric procedures in patients with left ventricular systolic dysfunction as compared to the general bariatric population. An echocardiographic subgroup showed a modest improvement in left ventricular ejection fraction in patients with systolic dysfunction who underwent bariatric surgery, with ejection fraction improvement more likely in patients without a baseline history of myocardial infarction. CrossRefPubMedGoogle Scholar
- 59.Ma IT, Madura JA. Gastrointestinal complications after bariatric surgery. Gastroenterol Hepatol. 2015;11:526–35.Google Scholar
- 65.Woelnerhanssen B, Peterli R, Steinert RE, Peters T, Borbély Y, Beglinger C. Effects of postbariatric surgery weight loss on adipokines and metabolic parameters: comparison of laparoscopic roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy—a prospective randomized trial. Surg Obes Relat Dis. 2011;7:561–8.CrossRefPubMedGoogle Scholar
- 68.Ikonomidis I, Mazarakis A, Papadopoulos C, Patsouras N, Kalfarentzos F, Lekakis J, et al. Weight loss after bariatric surgery improves aortic elastic properties and left ventricular function in individuals with morbid obesity: a 3-year follow-up study. J Hypertens. 2007;25:439–47.CrossRefPubMedGoogle Scholar
- 76.• Kaier TE, Morgan D, Grapsa J, Demir OM, Paschou SA, Sundar S, et al. Ventricular remodelling post-bariatric surgery: is the type of surgery relevant? A prospective study with 3D speckle tracking. Eur Heart J Cardiovasc Imaging. 2014;15:1256–62. A single-center study of obese patients without HF, highlighting the regression of biventricular hypertrophy and abnormal global longitudinal strain that follows successful surgical weight loss . CrossRefPubMedGoogle Scholar
- 77.•• Benotti PN, Wood GC, Carey DJ, Mehra VC, Mirshahi T, Lent MR, et al. Gastric bypass surgery produces a durable reduction in cardiovascular disease risk factors and reduces the long-term risks of congestive heart failure. J Am Heart Assoc. 2017;6:e005126. A cohort of RYGB patients was compared to a matched cohort of non-surgical obese patients, with follow-up for up to 12 years ( n = 1724 per cohort). There was a significantly lower rate of the composite cardiovascular endpoint in surgical group, as well as a lower rate of incident HF. CrossRefPubMedPubMedCentralGoogle Scholar
- 78.•• Persson CE, Björck L, Lagergren J, Lappas G, Giang KW, Rosengren A. Risk of heart failure in obese patients with and without bariatric surgery in Sweden—a registry-based study. J Card Fail. 2017;23:530–7. A cohort of 22,295 obese patients who underwent bariatric surgery (mostly RYGB) was compared to 25,564 obese patients who were managed non-surgically in Sweden. Even after covariate adjustment, the hazard of HF development was significantly lower in the surgical group than the non-surgical group. CrossRefPubMedGoogle Scholar
- 79.•• Sundström J, Bruze G, Ottosson J, Marcus C, Näslund I, Neovius M. Weight loss and heart failure: a nationwide study of gastric bypass surgery versus intensive lifestyle treatment. Circulation. 2017;135:1577–85. Patients who received bariatric surgery in the Scandinavian Obesity Surgery Registry ( n = 25,804) were compared to a nationwide registry of patients receiving a structured intensive lifestyle program ( n = 13,701) for obesity management. Over a median 4-year follow-up, surgical patients had a significantly lower hazard of HF development than the lifestyle modification patients. CrossRefPubMedPubMedCentralGoogle Scholar
- 84.Evangelista LS, Heber D, Li Z, Bowerman S, Hamilton MA, Fonarow GC. Reduced body weight and adiposity with a high-protein diet improves functional status, lipid profiles, glycemic control, and quality of life in patients with heart failure: a feasibility study. J Cardiovasc Nurs. 2009;24:207–15.CrossRefPubMedPubMedCentralGoogle Scholar
- 97.•• Shimada YJ, Tsugawa Y, Brown DFM, Hasegawa K. Bariatric surgery and emergency department visits and hospitalizations for heart failure exacerbation: population-based, self-controlled series. J Am Coll Cardiol. 2015;67:895–903. This was the first analysis of HF hospitalizations/emergency room visits for patients with obesity before and after bariatric surgery, using data from 3 US states. Amongst 524 patients, 16.2% had a HF hospitalization/emergency room visit in the time period 13–24 months prior to bariatric surgery. There was a non-significant reduction in HF visits in the first 12 months after bariatric surgery and a significantly reduction in months 13–24 after bariatric surgery (to 9.9%). CrossRefGoogle Scholar